ResMed

Yahoo Finance • 6 days ago

Global Anesthesia and Respiratory Devices Market Size/Share Worth USD 100.5 Billion by 2035 at a 5.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Anesthesia and Respiratory Devices Market size & share revenue was valued at approxim... Full story

Yahoo Finance • 12 days ago

Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026

SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2026 on Thursday, April 30, 2026, after the New York St... Full story

Yahoo Finance • 13 days ago

Is It Time To Revisit ResMed (RMD) After Recent Share Price Weakness?

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Wondering whether ResMed at around US$220 a share looks like a bargain or a potential value trap? This article walks through what... Full story

Yahoo Finance • 29 days ago

Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and CVS Health in focus

Wall Street’s major indexes ended lower on Friday as investors digested a fresh batch of economic data, highlighted by the latest PCE inflation and GDP reports. The benchmark S&P 500 ended -0.6%, the blue-chip Dow closed -0.2%, and the te... Full story

Yahoo Finance • last month

3 Reasons Not to Sleep on ResMed Stock

Key Points ResMed has been growing, and investing in further growth as well -- especially via digital technologies. Its stock is appealingly priced at recent levels. It's worth a closer look.10 stocks we like better than ResMed › I confe... Full story

Yahoo Finance • last month

3 Healthcare Stocks to Target This Week

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have seen decent returns lately as healthcare stocks were up 5.7% over the past six month... Full story

Yahoo Finance • last month

Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach

Resmed, Inc. Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains 53% of people surveyed rank sleep as the most important behavior for a long, healthy life, ahead of die... Full story

Yahoo Finance • last month

ResMed Expands Greenwood Hub As Investors Weigh Valuation And Soft Momentum

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. ResMed (NYSE:RMD) is opening a new major distribution center in Greenwood, Indiana, to support its... Full story

Yahoo Finance • 2 months ago

Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana

Resmed, Inc. Center to Create Local Jobs and Strengthen U.S. Healthcare Supply Resilience SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and ca... Full story

Yahoo Finance • 2 months ago

Anti-snoring Devices Market Competitive Landscape Report 2025: Top Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations and Launches, Sustainability Goals, Revenue Insights

Company Logo The anti-snoring devices market is set to expand from $1.81 billion in 2025 to $3.36 billion by 2033, reflecting an 8.04% CAGR. This growth is driven by rising obesity rates, innovative technologies, and demand for non-invasi... Full story

Yahoo Finance • 2 months ago

Sleep Aids: Trends, Technologies and Global Markets to 2030 Featuring Key Players Fisher & Paykel Healthcare, ResMed, Philips, Alphabet, Apple and More

Company Logo Growth is driven by rising disposable incomes, wellness trends, and demand for personalized solutions. Major players innovate with premium and accessible products. Sleep Aids MarketSleep Aids Market·GlobeNewswire Inc. Dubli... Full story

Yahoo Finance • 2 months ago

ResMed Inc. (RMD) Gains Analyst Confidence as Price Targets Rise on Strong Earnings

ResMed Inc. (NYSE:RMD) is one of the best medical technology stocks to invest in. On January 30, KeyBanc Capital Markets lifted its price target on ResMed Inc. (NYSE:RMD) to $302 from $299 and maintained an Overweight rating.ResMed Inc. (R... Full story

Yahoo Finance • 2 months ago

ResMed (RMD) Valuation Check After Strong Earnings And Dividend Update

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. ResMed (RMD) is back in focus after reporting higher sales and net income for its second quarter and first half of fis... Full story

Yahoo Finance • 4 months ago

Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44th Annual J.P. Morgan Health... Full story

Yahoo Finance • 4 months ago

Wall Street searches for guidance as investors await Fed's rate decision

[Republican Politics and Wall Street] Douglas Rissing Wall Street's major averages were mixed, swinging on both sides of the flat line on Wednesday as all focus is on the Federal Reserve's final interest rate decision of the year this aft... Full story

Yahoo Finance • 4 months ago

Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy

SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has received U.S. Food and Drug Administratio... Full story

Yahoo Finance • 4 months ago

Is It Too Late To Consider ResMed After Obesity and Sleep Apnea Headlines?

If you are wondering whether ResMed is still attractive after its strong run, or if the market has already priced in the upside, this article will help you cut through the noise and focus on what the numbers indicate about its value. ResMe... Full story

Yahoo Finance • 4 months ago

Healthcare & Biotech Stocks Rally After Hours: Sensei, Praxis, Cooper, Vanda, Cue, ResMed

(RTTNews) - Several healthcare and biotech names posted notable gains in Thursday's after-hours session, driven by clinical updates, earnings results, and regulatory developments. Sensei Biotherapeutics Inc. (SNSE) soared 62.9% to $17.20... Full story

Yahoo Finance • 4 months ago

LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea

LONDON, December 02, 2025--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced Lucile Blaise has joined the Company as Global Head of Commercialization, Obstructive Sleep Apnea (OSA), effect... Full story

Yahoo Finance • 5 months ago

Sleep Apnea Devices Market Competitor Analysis Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts

Company Logo The Sleep Apnea Devices industry is set to grow from US$ 6.47 Billion in 2024 to an impressive US$ 12.23 Billion by 2033, at a CAGR of 7.32% from 2025 to 2033. This surge is driven by increasing sleep disorder rates, notably... Full story